Effects of tranexamic acid on the recovery of osteochondral defects treated by microfracture and acellular matrix scaffold: an experimental study

Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in or...

Full description

Saved in:
Bibliographic Details
Published inJournal of orthopaedic surgery and research Vol. 14; no. 1; pp. 105 - 8
Main Authors Degirmenci, Erdem, Ozturan, Kutay Engin, Sahin, Abdullah Alper, Yilmaz, Fahri, Kaya, Yasin Emre
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 15.04.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits. This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O'Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant. Samples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O' Driscoll scores in both weeks were statistically higher in group 1. Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.
AbstractList Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits. This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O'Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant. Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.
Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits. This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O'Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant. Samples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O' Driscoll scores in both weeks were statistically higher in group 1. Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.
Background Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits. Methods This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O’Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant. Results Samples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O’ Driscoll scores in both weeks were statistically higher in group 1. Conclusions Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.
Abstract Background Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits. Methods This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O’Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant. Results Samples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O’ Driscoll scores in both weeks were statistically higher in group 1. Conclusions Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.
Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits.BACKGROUNDMicrofracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits.This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O'Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant.METHODSThis paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O'Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant.Samples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O' Driscoll scores in both weeks were statistically higher in group 1.RESULTSSamples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O' Driscoll scores in both weeks were statistically higher in group 1.Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.CONCLUSIONSApplication of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.
Background Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits. Methods This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O'Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant. Results Samples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O' Driscoll scores in both weeks were statistically higher in group 1. Conclusions Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects. Keywords: Osteochondral defect, Microfracture, A-cellular scaffold, Tranexamic acid
ArticleNumber 105
Audience Academic
Author Kaya, Yasin Emre
Sahin, Abdullah Alper
Yilmaz, Fahri
Degirmenci, Erdem
Ozturan, Kutay Engin
Author_xml – sequence: 1
  givenname: Erdem
  orcidid: 0000-0002-7988-4261
  surname: Degirmenci
  fullname: Degirmenci, Erdem
– sequence: 2
  givenname: Kutay Engin
  surname: Ozturan
  fullname: Ozturan, Kutay Engin
– sequence: 3
  givenname: Abdullah Alper
  surname: Sahin
  fullname: Sahin, Abdullah Alper
– sequence: 4
  givenname: Fahri
  surname: Yilmaz
  fullname: Yilmaz, Fahri
– sequence: 5
  givenname: Yasin Emre
  surname: Kaya
  fullname: Kaya, Yasin Emre
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30992060$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1u1TAQhSNURH_gAdggS2y6SfHE-bFZIFVVgUqV2IDEznLsyb2ucuNiO1XvY_DGTLgttBXIi1jjcz5nxuew2JvChEXxGvgJgGzfJRAcZMlBlQB1XXbPigPoalV2Sn3fe7DfLw5TuuK84Y2sXxT7gitV8ZYfFD_PhwFtTiwMLEcz4a3ZeMuM9Y6FieU1sog23GDcLpKQMga7DpOLZmQOd94c0WR0rN8yMscwRGPzHJGZyREKx3EeTWQbk6O_ZcmaYQije0_HDG-vMfoNTpl4Kc9u-7J4Ppgx4au771Hx7eP517PP5eWXTxdnp5elbVqeSweNw17WjWgbiw5EI41UfY-CLuSy5q2wVHBcGOF6Ka1oB5A9WaTgtkFxVFzsuC6YK31NP2HiVgfj9e9CiCttYvZ2RM2hhmroZSVR1dAo1bcdIDa9NKbvVE-sDzvW9dxv0Flqh-bzCPr4ZPJrvQo3uq1bBdAQ4PgOEMOPGVPWG5-WwdGLhDnpqgKu2la1FUnfPpFehTlONKpFBbVQlRB_VStDDfhpCHSvXaD6tJECpOgASHXyDxUth_SQFLbBU_2R4c3DRv90eB8oEnQ7AcUgpYiDtj6b7MPStx81cL1EV--iS5NVeomu7sgJT5z38P97fgESp_Jq
CitedBy_id crossref_primary_10_1007_s00167_020_06219_7
crossref_primary_10_1016_j_arthro_2023_08_019
crossref_primary_10_3389_fbioe_2021_812383
crossref_primary_10_5312_wjo_v13_i6_555
crossref_primary_10_1177_03635465231220855
crossref_primary_10_3390_polym13203470
crossref_primary_10_1016_j_injury_2020_09_008
crossref_primary_10_1097_PRS_0000000000008884
crossref_primary_10_7759_cureus_14873
crossref_primary_10_3389_fmed_2024_1352967
crossref_primary_10_3390_ph17121576
Cites_doi 10.3109/17453679608994664
10.2106/JBJS.15.01208
10.1016/j.injury.2008.01.042
10.2106/00004623-198870040-00017
10.1007/s00167-011-1777-5
10.1016/j.arth.2018.04.043
10.1016/j.biomaterials.2011.06.018
10.5312/wjo.v5.i4.444
10.1016/j.biomaterials.2007.09.005
10.1007/s10561-011-9290-0
10.1177/0363546516629434
10.1177/036354659702500624
10.1016/j.joca.2011.07.004
10.1007/s11999-011-2107-4
10.1007/s00167-010-1042-3
10.1053/jars.2003.50112
10.1002/jor.20879
10.1177/1947603515611949
10.1016/j.joca.2004.12.016
10.1016/j.arthro.2005.06.018
10.1007/s00402-012-1621-5
10.1016/j.arthro.2013.05.027
10.2106/00004623-200710000-00002
10.2106/JBJS.RVW.17.00103
10.1089/ten.teb.2009.0452
10.1007/s00167-013-2747-x
10.2147/DDDT.S175407
10.1177/0363546514528093
10.1016/0142-9612(93)90160-4
10.1242/jcs.00912
10.1177/0363546508328414
10.1302/0301-620X.100B3.BJJ-2017-1135.R1
10.1007/s12306-013-0242-7
10.2165/00003495-198529030-00003
10.1016/j.arthro.2016.06.035
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13018-019-1144-7
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
Publicly Available Content Database

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1749-799X
EndPage 8
ExternalDocumentID oai_doaj_org_article_01412fb828e941599b671ee5b8aab79b
PMC6469115
A583183711
30992060
10_1186_s13018_019_1144_7
Genre Journal Article
GeographicLocations Turkey
GeographicLocations_xml – name: Turkey
GrantInformation_xml – fundername: Düzce Üniversitesi
  grantid: 45199058/050.01.04/
– fundername: ;
  grantid: 45199058/050.01.04/
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IPT
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TUS
UKHRP
WOQ
WOW
~8M
NPM
PMFND
3V.
7QP
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c560t-d15deb845365ced1358a89bbe3ace084063ca89d03a3db88c36f18beb8830c5e3
IEDL.DBID 7X7
ISSN 1749-799X
IngestDate Wed Aug 27 01:27:19 EDT 2025
Thu Aug 21 18:01:30 EDT 2025
Fri Jul 11 00:44:18 EDT 2025
Fri Jul 25 21:06:31 EDT 2025
Tue Jun 17 21:37:35 EDT 2025
Tue Jun 10 20:47:27 EDT 2025
Thu Apr 03 07:03:52 EDT 2025
Tue Jul 01 02:17:20 EDT 2025
Thu Apr 24 22:58:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords A-cellular scaffold
Tranexamic acid
Microfracture
Osteochondral defect
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-d15deb845365ced1358a89bbe3ace084063ca89d03a3db88c36f18beb8830c5e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7988-4261
OpenAccessLink https://www.proquest.com/docview/2211439233?pq-origsite=%requestingapplication%
PMID 30992060
PQID 2211439233
PQPubID 55349
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_01412fb828e941599b671ee5b8aab79b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469115
proquest_miscellaneous_2210966962
proquest_journals_2211439233
gale_infotracmisc_A583183711
gale_infotracacademiconefile_A583183711
pubmed_primary_30992060
crossref_citationtrail_10_1186_s13018_019_1144_7
crossref_primary_10_1186_s13018_019_1144_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-04-15
PublicationDateYYYYMMDD 2019-04-15
PublicationDate_xml – month: 04
  year: 2019
  text: 2019-04-15
  day: 15
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of orthopaedic surgery and research
PublicationTitleAlternate J Orthop Surg Res
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References K Midhoefer (1144_CR29) 2009; 37
1144_CR34
JR Tuttle (1144_CR42) 2015; 44
JL Cook (1144_CR7) 2016; 44
JA Buckwalter (1144_CR2) 1997; 25
LA Solchaga (1144_CR9) 2005; 13
C Erggelet (1144_CR12) 2007; 28
A Rastrelli (1144_CR5) 1990; 9
CC Wang (1144_CR8) 2011; 32
JD Parker (1144_CR41) 2018; 100-B
P Sitek (1144_CR20) 2013; 14
GP Dowthwaite (1144_CR3) 2004; 117
1144_CR18
J Insall (1144_CR27) 1974; 101
S Bark (1144_CR25) 2014; 5
D Goyal (1144_CR35) 2013; 29
YA Fillingham (1144_CR39) 2018; 33
K Messner (1144_CR1) 1996; 67
C Albrecht (1144_CR10) 2011; 19
J Gille (1144_CR26) 2010; 18
L Benedetti (1144_CR6) 1993; 14
G Knutsen (1144_CR36) 2007; 89
J Gille (1144_CR24) 2013; 133
1144_CR22
E Cholewinski (1144_CR14) 2009; 15
LF Ambra (1144_CR19) 2017; Nov 8
1144_CR40
A Siclari (1144_CR11) 2012; 470
SW O’Driscoll (1144_CR23) 1988; 70A
A Marmotti (1144_CR16) 2016; 30
CR Chu (1144_CR17) 2010; 16
M Verstraete (1144_CR21) 1985; 3
MR Steinwachs (1144_CR4) 2008; 39
KF Schuttler (1144_CR32) 2014; 22
G Knutsen (1144_CR37) 2016; 98
C Bauer (1144_CR13) 2016; 7
C Erggelet (1144_CR31) 2009; 27
D Saris (1144_CR38) 2014; 42
FC Kuo (1144_CR15) 2018; 12
JR Steadman (1144_CR28) 2003; 19
R Gudas (1144_CR30) 2005; 21
H Sofu (1144_CR33) 2017; 33
References_xml – volume: 67
  start-page: 165
  year: 1996
  ident: 1144_CR1
  publication-title: Acta Orthop Scand
  doi: 10.3109/17453679608994664
– volume: 98
  start-page: 1332
  year: 2016
  ident: 1144_CR37
  publication-title: J Bone Joint Surg Am
  doi: 10.2106/JBJS.15.01208
– volume: 39
  start-page: 26
  year: 2008
  ident: 1144_CR4
  publication-title: Injury
  doi: 10.1016/j.injury.2008.01.042
– volume: 15
  start-page: 1
  year: 2009
  ident: 1144_CR14
  publication-title: Tissue Eng
– volume: 9
  start-page: 199
  year: 1990
  ident: 1144_CR5
  publication-title: Clin Implant Mater
– volume: 70A
  start-page: 595
  year: 1988
  ident: 1144_CR23
  publication-title: J Bone Joint Surg
  doi: 10.2106/00004623-198870040-00017
– ident: 1144_CR34
  doi: 10.1007/s00167-011-1777-5
– volume: 33
  start-page: 3090
  issue: 10
  year: 2018
  ident: 1144_CR39
  publication-title: J Arthroplasty
  doi: 10.1016/j.arth.2018.04.043
– volume: 32
  start-page: 7118
  year: 2011
  ident: 1144_CR8
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.06.018
– volume: 5
  start-page: 444
  issue: 4
  year: 2014
  ident: 1144_CR25
  publication-title: World J Orthop
  doi: 10.5312/wjo.v5.i4.444
– volume: 28
  start-page: 5570
  year: 2007
  ident: 1144_CR12
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2007.09.005
– volume: 14
  start-page: 133
  year: 2013
  ident: 1144_CR20
  publication-title: Cell Tissue Bank
  doi: 10.1007/s10561-011-9290-0
– volume: 44
  start-page: 1260
  year: 2016
  ident: 1144_CR7
  publication-title: Am J Sports Med
  doi: 10.1177/0363546516629434
– volume: 25
  start-page: 873
  year: 1997
  ident: 1144_CR2
  publication-title: Am J Sports Med
  doi: 10.1177/036354659702500624
– volume: 44
  start-page: 497
  year: 2015
  ident: 1144_CR42
  publication-title: Am J Orthop
– volume: 19
  start-page: 1219
  year: 2011
  ident: 1144_CR10
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2011.07.004
– volume: 470
  start-page: 910
  year: 2012
  ident: 1144_CR11
  publication-title: Clin Orthop Relat Res
  doi: 10.1007/s11999-011-2107-4
– volume: 101
  start-page: 61
  year: 1974
  ident: 1144_CR27
  publication-title: Clin Orthop Relat Res
– volume: 18
  start-page: 1456
  issue: 11
  year: 2010
  ident: 1144_CR26
  publication-title: Knee Surg Sports Traumatol Arthrosc
  doi: 10.1007/s00167-010-1042-3
– volume: 19
  start-page: 477
  issue: 5
  year: 2003
  ident: 1144_CR28
  publication-title: Arthroscopy
  doi: 10.1053/jars.2003.50112
– volume: 27
  start-page: 1353
  year: 2009
  ident: 1144_CR31
  publication-title: Inc J Orthop Res
  doi: 10.1002/jor.20879
– volume: 7
  start-page: 265
  year: 2016
  ident: 1144_CR13
  publication-title: Cartilage
  doi: 10.1177/1947603515611949
– volume: 13
  start-page: 297
  year: 2005
  ident: 1144_CR9
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2004.12.016
– volume: 21
  start-page: 1066
  year: 2005
  ident: 1144_CR30
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2005.06.018
– volume: 133
  start-page: 87
  year: 2013
  ident: 1144_CR24
  publication-title: Arch Orthop Trauma Surg
  doi: 10.1007/s00402-012-1621-5
– volume: 29
  start-page: 1579
  issue: 9
  year: 2013
  ident: 1144_CR35
  publication-title: Arthroscopy
  doi: 10.1016/j.arthro.2013.05.027
– volume: 89
  start-page: 2105
  year: 2007
  ident: 1144_CR36
  publication-title: J Bone Joint Surg Am.
  doi: 10.2106/00004623-200710000-00002
– ident: 1144_CR40
  doi: 10.2106/JBJS.RVW.17.00103
– volume: 16
  start-page: 105
  year: 2010
  ident: 1144_CR17
  publication-title: Tissue Eng Part B Rev
  doi: 10.1089/ten.teb.2009.0452
– volume: 22
  start-page: 1270
  year: 2014
  ident: 1144_CR32
  publication-title: Knee Surg Sports Traumatol Arthrosc
  doi: 10.1007/s00167-013-2747-x
– volume: 12
  start-page: 3163
  year: 2018
  ident: 1144_CR15
  publication-title: Drug Des Devel Ther
  doi: 10.2147/DDDT.S175407
– ident: 1144_CR18
– volume: Nov 8
  start-page: 4746
  year: 2017
  ident: 1144_CR19
  publication-title: Knee Surg Sports Traumatol Arthrosc
– volume: 42
  start-page: 1384
  issue: 6
  year: 2014
  ident: 1144_CR38
  publication-title: Am J Sports Med
  doi: 10.1177/0363546514528093
– volume: 14
  start-page: 1135
  issue: 15
  year: 1993
  ident: 1144_CR6
  publication-title: Biomaterials
  doi: 10.1016/0142-9612(93)90160-4
– volume: 117
  start-page: 889
  year: 2004
  ident: 1144_CR3
  publication-title: J Cell Sci
  doi: 10.1242/jcs.00912
– volume: 37
  start-page: 2053
  year: 2009
  ident: 1144_CR29
  publication-title: Am J Sports Med
  doi: 10.1177/0363546508328414
– volume: 100-B
  start-page: 404
  issue: 3
  year: 2018
  ident: 1144_CR41
  publication-title: Bone Joint J
  doi: 10.1302/0301-620X.100B3.BJJ-2017-1135.R1
– ident: 1144_CR22
  doi: 10.1007/s12306-013-0242-7
– volume: 3
  start-page: 236
  year: 1985
  ident: 1144_CR21
  publication-title: Drugs
  doi: 10.2165/00003495-198529030-00003
– volume: 30
  start-page: 33
  year: 2016
  ident: 1144_CR16
  publication-title: J Biol Regul Homeost Agents
– volume: 33
  start-page: 209
  year: 2017
  ident: 1144_CR33
  publication-title: J Arthroscopic and Related Surg
  doi: 10.1016/j.arthro.2016.06.035
SSID ssj0050584
Score 2.2190182
Snippet Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most...
Background Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The...
Abstract Background Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 105
SubjectTerms A-cellular scaffold
Analysis
Antifibrinolytic agents
Biomedical materials
Bone surgery
Cartilage
Collagen
Data processing
Defects
Femur
Fibrin
Hemostatic agents
Joint surgery
Knee
Microfracture
NMR
Nuclear magnetic resonance
Orthopedic surgery
Orthopedics
Osteochondral defect
Rabbits
Statistical analysis
Studies
Surgery
Systematic review
Tranexamic acid
Transplants & implants
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9UwEA6yT76I4q26SgRBEMq2SXPzbRWXRdAnF_Yt5DLBhbOt7DkHdn-G_9iZtudwiqAvvjaZtkkmM9-QyTeMvRVOGwc6ovVTpu5yaepoiIswQ6BzLalGdv6v3_T5RfflUl0elPqinLCJHniauBNKRBQlYmAADp2Nc1GbFkBFG0I0LpL1RZ-3C6YmG4xu3XbzGWZr9ckaLXVLSVuuRvzf1WbhhUay_j9N8oFPWuZLHjigs4fswYwc-en0x4_YPegfs18T-_CaD4WjUA-3VF-eh3SV-dBzRHecQl7U1zvqQjc6BjR4fcYP8AyT7JhsDpnHO35N-XmFbk5tb4CHPuOrYLWiXFV-TWz-t3ydQinDKn_AZn5YIICPVLVP2MXZ5--fzuu5ykKdEO1s6tyqDNF2SmqVILdS2WBdjCDxAw3Gf1omfJAbGWSO1iapS2sjiljZJAXyKTvqhx6eM45QMzWxmCY61wkQtiQCJAix0LAUESrW7Gbdp5mCnCphrPwYiljtp4XyuFB0XbrzpmLv9yI_J_6Nv3X-SEu570jU2eMDVCg_K5T_l0JV7B0pgqcNjj-XwnxPAYdIVFn-VFmyg6ZtK3a86IkbMy2bd6rkZ8Ow9gIDbsSAQsqKvdk3kyQlu_UwbMc-GFhqp0XFnk2atx-SREQvGt1UzCx0cjHmZUt_9WOkDdedRs-mXvyPSXrJ7gvaTUR6qY7Z0eZmC68QnW3i63Ej_gYjHzfK
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9UwEA7r-uKLrHjr7ioRBEGotk1zE0RWcVmE9ckD-xaamy50Wz0XOOdn-I-dSXsOp7jsa5Npm2Qm8w2ZfEPI60oLqYOwsPtxmdc-FrmVyEXoQ4PnWowndv7L7-JiVn-74lcHZFveapzAxa2hHdaTms3bd-s_m09g8B-TwSvxfgH7cIkpWToHdF_n8h65D45JYkGDy3p3qAC-XtXjweatYhPXlBj8_9-n9xzVNIlyzyudH5GHI5ykZ8P6PyIHoXtM_g6UxAvaRwpCXVhj0XnauGtP-44C5KMYB4MSb7ALXvPoYSI6Dx-gPgyyKQM9eGo39AaT9iJep1rNA206D68KbYsJrPQGKf7XdOGaGPvWf4Bmul81gCb-2idkdv71x5eLfCy9kDuAQMvcl9wHq2rOBHfBl4yrRmlrA4MPFBAUCubggS9Yw7xVyjERS2VBRLHC8cCeksOu78JzQgF_usJGWVit6ypUKjpEKYC7YLeJVZORYjvrxo285FgeozUpPlHCDAtlYKHwDnVtZEbe7kR-D6Qcd3X-jEu564h82ulBP_9pRvM0mO5aRQvhZ9AAabS2QpYhcKuaxkptM_IGFcGgHsLPuWa8vABDRP4sc8YVbo6yLDNyOukJ1uqmzVtVMltlNxVE4QAMK8Yy8mrXjJKYAdeFfpX6QLQptKgy8mzQvN2QGMD8qhBFRuREJydjnrZ0178Sl7ioBbg7fnz3b52QBxXaCXJc8lNyuJyvwgsAY0v7MpnYP5v5Mmk
  priority: 102
  providerName: Scholars Portal
Title Effects of tranexamic acid on the recovery of osteochondral defects treated by microfracture and acellular matrix scaffold: an experimental study
URI https://www.ncbi.nlm.nih.gov/pubmed/30992060
https://www.proquest.com/docview/2211439233
https://www.proquest.com/docview/2210966962
https://pubmed.ncbi.nlm.nih.gov/PMC6469115
https://doaj.org/article/01412fb828e941599b671ee5b8aab79b
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdb-7KXsbEvb13QYDAYmNqW9dWXkY6WEmgZ2wp5E9aHt0Jqd3EC7Z_R_3h3spPFDPqSgHVnW9bpPqTT7wj5WGghdRAWtB-XaenrLLUSsQh9qHBfi_GIzn9-Ic4uy9mcz4cFt25Iq9zoxKiofetwjfywgEgFjGfB2JebPylWjcLd1aGExmOyj9BlKNVyvg24wLirctjJzJU47EBf55i6pVO4V5nKkS2KkP3_K-YdyzTOmtwxQ6fPyNPBf6TTfsCfk0eheUHuewzijrY1BaYm3GKVeVq5K0_bhoKPRzHwBam9QxI819GC2ms8PID60PPGlPPgqb2j15ilV-P5qfUy0KrxcKuwWGDGKr1GTP9b2rmqrtuFP4JmulsmgEbA2pfk8vTk59ezdKi1kDrweVapz7kPVpWcCe6CzxlXldLWBgYPyCAKFMzBBZ-xinmrlGOizpUFFsUyxwN7RfaatglvCAWH02W2lpnVuixCoWqHbgk4WqBe6qJKSLb56sYNQORYD2NhYkCihOkHysBA4aHp0siEfN6y3PQoHA8RH-NQbgkRQDteaJe_zDAfDea3FrWFeDNo8GG0tkLmIXCrqspKbRPyCQXB4DSHl3PVcFoBuoiAWWbKFWpDmecJORhRwvR04-aNKJlBPXTmnzAn5MO2GTkx5a0J7TrSQHgptCgS8rqXvG2XGPj1RSayhMiRTI76PG5prn5H8HBRCrBv_O3Dr_WOPClwniCoJT8ge6vlOrwH72tlJ3GKTcj-dDr7MYP_45OLb98ncS0Dfs9L9RdSBTRh
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw1CrlABcEYgsUMBIICSlqYseOjYRQWaopXU6t1JvxFqg0TcosovMZ_AjfyHtJZpgIqbde4_cy9rw9fgshr5iWpY7SgfYTZVqEKktdib0IQ7R4r8VF253_8EiOToqvp-J0g_xZ1sJgWuVSJ7aKOjQev5FvM4hUwHgyzj9c_ExxahTeri5HaHRssR8XvyBkm77f-wz0fc3Y7pfjT6O0nyqQerDuszTkIkSnCsGl8DHkXCirtHORWx8ziHck9_AgZNzy4JTyXFa5coCieOZF5PDeG-QmGN4Mg73ydBXggTOhiv7mNFdyewr2IcdUMZ3C3ou0HNi-dkTA_4ZgzRIOszTXzN7uXXKn91fpTsdg98hGrO-T313P4yltKgpIdbzEqfbU-rNAm5qCT0kx0AYpWSAI1pE0oGbrAD9AQ-xw2xT3GKhb0HPMCqywXms-idTWAV4Vx2PMkKXnOEPgkk69rapmHN7BMl0fS0DbBrkPyMm1UOEh2aybOj4mFBxcn7mqzJzWBYtMVR7dIHDsQJ1VzCYkW_7rxveNz3H-xti0AZCSpiOUAUJhkXZhyoS8XaFcdF0_rgL-iKRcAWLD7vZBM_luevk3mE_LKgfxbdTgM2ntZJnHKJyy1pXaJeQNMoJBtQKb87avjoAjYoMusyMUat8yzxOyNYAEdeCHy0tWMr06mpp_wpOQl6tlxMQUuzo28xYGwlmpJUvIo47zVkfiEEewTGYJKQc8OTjzcKU--9E2K5eFBHsqnly9rRfk1uj48MAc7B3tPyW3GcoMNtQUW2RzNpnHZ-D5zdzzVtwo-Xbd8v0XK4xtLQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+tranexamic+acid+on+the+recovery+of+osteochondral+defects+treated+by+microfracture+and+acellular+matrix+scaffold%3A+an+experimental+study&rft.jtitle=Journal+of+orthopaedic+surgery+and+research&rft.au=Degirmenci%2C+Erdem&rft.au=Kutay+Engin+Ozturan&rft.au=Abdullah+Alper+Sahin&rft.au=Yilmaz%2C+Fahri&rft.date=2019-04-15&rft.pub=BioMed+Central&rft.eissn=1749-799X&rft.volume=14&rft_id=info:doi/10.1186%2Fs13018-019-1144-7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1749-799X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1749-799X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1749-799X&client=summon